Lv5
1245 积分 2020-11-11 加入
Patient-derived tumor xenograft study with CDK4/6 inhibitor plus AKT inhibitor for the management of metastatic castration-resistant prostate cancer
2天前
已完结
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
17天前
已完结
Crystallographic analysis of G-clamp–RNA complex assisted by large scale RNA-binding profile
17天前
已完结
Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
26天前
已完结
Combinatorial drug therapy for cancer in the post-genomic era
27天前
已完结
Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy
27天前
已完结
CDK4/6 inhibition triggers anti-tumour immunity
27天前
已完结
Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation Approach
27天前
已完结
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
27天前
已完结
Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27 Kip1 Activity
27天前
已关闭
皖公网安备34019202002308
